Dr. Ralph V. Boccia, MD

Dr. Boccia practices at American Oncology Partners PA in Asheville, North Carolina.

Dr. Boccia's NPI, 1881663284, was assigned on March 16, 2006. Dr. Boccia graduated from University of Minnesota Medical School in 1977. Dr. Boccia holds Maryland license D29675.

Dr. Boccia's primary practice is American Oncology Partners PA, at 551 Brevard Rd, Asheville, NC 28806 in Buncombe County. The practice phone is (614) 383-6000.

Dr. Boccia's primary practice is American Oncology Partners PA in Asheville, North Carolina. Dr. Boccia is also affiliated with Sibley Memorial Hospital. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Dr. Boccia to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boccia practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Boccia's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Boccia is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Boccia's licenses on file in 5 states: Maryland, California, District of Columbia, New Jersey and Minnesota.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Boccia treats.

CMS data shows 232,478 Medicare services from Dr. Boccia across 51 procedure codes in 2024, for 894 Medicare patients. Medicare paid $2,791,365 for them. Every service was in an office.

CMS counts 894 Medicare patients who saw Dr. Boccia in 2024. The largest group is 75 to 84, with 338 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boccia's median patient age at 67, with 65% women.

In 2024, Dr. Boccia wrote 1,064 Medicare Part D claims for 164 patients. 43% of them were for generic drugs. CMS names the drug for 829 of them, across 26 drugs with 11 or more claims each, at $5,853,193 in total drug cost. In 2023, CMS named 694 claims across 24 drugs.

Dr. Boccia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boccia as offering telehealth.

Dmand AI links 61 papers to Dr. Boccia, published from 2010 to 2024. 2018 was the busiest year, with 5. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents and Multiple Myeloma. Dr. Boccia has published most often in Br J Haematol. Dr. Boccia's most frequent co-authors are Ruben Niesvizky, MD, James Richard Berenson, MD and Gail L. Brown, MD.

Dmand AI links Dr. Boccia to 20 clinical trials, 9 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Lymphoma, Non-Hodgkin and Lymphoma, T-Cell, Peripheral. Veeda Oncology sponsors the most, 3. Open Payments lists research payments to Dr. Boccia that name 2 trials.

CMS Open Payments shows 5,286 general payments to Dr. Boccia from 120 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 56% of the total. Bristol-Myers Squibb Company paid the most, $502,883. It also lists 41 research payments totaling $120,730 from 2016 to 2024, naming 2 clinical trials.

Dmand AI lists 6 awards for Dr. Boccia, most recently Super Doc in 2013.

Dr. Boccia graduated from University of Minnesota Medical School in 1977. Dr. Boccia is a member of ASCO.

Dr. Boccia is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.